Future Development Plan - sun pharma advanced research company
... cancers. Somatostatin has a short half life and needs 3-4 injections daily SPARC has developed Octreotide depot 1M Inj. capable of maintaining therapeutic plasma levels for one month following a single injection. ...
... cancers. Somatostatin has a short half life and needs 3-4 injections daily SPARC has developed Octreotide depot 1M Inj. capable of maintaining therapeutic plasma levels for one month following a single injection. ...
Another Mix-up between Choral Hydrate and
... The chronology of the events in this case is of interest because it illustrates deficiencies in the medication system across the continuum of care, beginning with a “picking error” at the drug distribution warehouse, which was not detected when the medication was received at the community pharmacy. T ...
... The chronology of the events in this case is of interest because it illustrates deficiencies in the medication system across the continuum of care, beginning with a “picking error” at the drug distribution warehouse, which was not detected when the medication was received at the community pharmacy. T ...
Glycopyrronium (as bromide) - Therapeutic Goods Administration
... Information was approved at the time this AusPAR was published. latter study, the improvement vs. placebo for the open-label tiotropium 18 microgram oncedaily arm was 0.083 L (p < 0.001). In both studies SEEBRI BREEZHALER demonstrated a rapid onset of bronchodilator effect. In the 6-month study the ...
... Information was approved at the time this AusPAR was published. latter study, the improvement vs. placebo for the open-label tiotropium 18 microgram oncedaily arm was 0.083 L (p < 0.001). In both studies SEEBRI BREEZHALER demonstrated a rapid onset of bronchodilator effect. In the 6-month study the ...
BioRay Kids Line Guide
... other toxins in their home, school, and lawn, on playgrounds, and public parks. These substances enter their small bodies through the skin, lungs, mouth, and eyes. ...
... other toxins in their home, school, and lawn, on playgrounds, and public parks. These substances enter their small bodies through the skin, lungs, mouth, and eyes. ...
Presentation for Investors
... the innovation solution for bad breath • ‘Like’ novel platform technology focus on removing the causes of Halitosis and other conditions of the mouth /tongue • 'Like' comes in a form of combined lollipop/breath mint/tongue scraper with microcapsules of Zinc • Zinc is known as an active ingredient th ...
... the innovation solution for bad breath • ‘Like’ novel platform technology focus on removing the causes of Halitosis and other conditions of the mouth /tongue • 'Like' comes in a form of combined lollipop/breath mint/tongue scraper with microcapsules of Zinc • Zinc is known as an active ingredient th ...
Dabigatran
... • Each drug has its own effect in lab tests. • The metabolic mechanisms of each drug differ; see drug interactions. • Each drug has to be managed individually. ...
... • Each drug has its own effect in lab tests. • The metabolic mechanisms of each drug differ; see drug interactions. • Each drug has to be managed individually. ...
review - International Research Journal of Pharmacy
... removal of the probe mechanically breaks it. The force required to pull the probe away from the adhesive at fixed rate is recorded as tack and it is expressed in grams.17 In vitro drug release studies The paddle over disc method (USP apparatus V) can be employed for assessment of the release of the ...
... removal of the probe mechanically breaks it. The force required to pull the probe away from the adhesive at fixed rate is recorded as tack and it is expressed in grams.17 In vitro drug release studies The paddle over disc method (USP apparatus V) can be employed for assessment of the release of the ...
MANAGEMENT SCIENCE
... their beliefs about products. Thus, in our model, substitution between products may occur when a new online review is published. Figure 1 shows a simplistic example of how a review may influence consumer’s beliefs about a given product feature, in this case image quality. The consumer has an initial ...
... their beliefs about products. Thus, in our model, substitution between products may occur when a new online review is published. Figure 1 shows a simplistic example of how a review may influence consumer’s beliefs about a given product feature, in this case image quality. The consumer has an initial ...
Product Monograph Template - Standard
... Geriatrics (> 65 years of age): Of the total number of subjects in clinical studies of ULORIC®, 16% were 65 and over, while 4% were 75 and over. Comparing subjects in different age groups, no clinically significant differences in safety or efficacy were observed but greater sensitivity of some older ...
... Geriatrics (> 65 years of age): Of the total number of subjects in clinical studies of ULORIC®, 16% were 65 and over, while 4% were 75 and over. Comparing subjects in different age groups, no clinically significant differences in safety or efficacy were observed but greater sensitivity of some older ...
Richard E. Besser, MD Acting Director Centers for Disease Control and Prevention
... change over time. Emergence of resistance mutations could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and trea ...
... change over time. Emergence of resistance mutations could decrease drug effectiveness. Other factors (for example, changes in viral virulence) might also diminish clinical benefit of antiviral drugs. Prescribers should consider available information on influenza drug susceptibility patterns and trea ...
the concepts of efficacy and safety
... completely efficacious. In the beginning of this chapter, a safe technology was described intuitively as one that “causes no undue harm. ” Despite the apparent simplicity of that informal definition, it reflects a critical property of the concept of safety: that safety represents a value judgment of ...
... completely efficacious. In the beginning of this chapter, a safe technology was described intuitively as one that “causes no undue harm. ” Despite the apparent simplicity of that informal definition, it reflects a critical property of the concept of safety: that safety represents a value judgment of ...
Comprehensive Translational Assessment of Human Induced
... multichannel effects, where the deleterious effect of hERG potassium channel block may be balanced out by the drug effect on inward currents, as is the case for several marketed drugs (e.g., verapamil also blocks L-type calcium current, ranolazine blocks late sodium current) (Johannesen et al. 2014) ...
... multichannel effects, where the deleterious effect of hERG potassium channel block may be balanced out by the drug effect on inward currents, as is the case for several marketed drugs (e.g., verapamil also blocks L-type calcium current, ranolazine blocks late sodium current) (Johannesen et al. 2014) ...
an extension of biopharmaceutics classification system
... The term biowaiver is applied to a regulatory drug approval process when the dossier (application) is approved based on evidence of equivalence other than through in vivo equivalence testing. Biowaiver means to obtain waive off for carrying out expensive and time-consuming BA and BE studies. BCS pro ...
... The term biowaiver is applied to a regulatory drug approval process when the dossier (application) is approved based on evidence of equivalence other than through in vivo equivalence testing. Biowaiver means to obtain waive off for carrying out expensive and time-consuming BA and BE studies. BCS pro ...
formulation development and evaluation of sustained release
... In recent years, the number of commercially available antiepileptic drugs (AEDs) has increased steadily. Although this may complicate management choices, it also offers welcome new options to individualize treatment more effectively. Because each of the available AEDs differs from others in many cli ...
... In recent years, the number of commercially available antiepileptic drugs (AEDs) has increased steadily. Although this may complicate management choices, it also offers welcome new options to individualize treatment more effectively. Because each of the available AEDs differs from others in many cli ...
Pharmacologic Treatment Options for Obesity: What Is Old Is New Again
... finally released on the market in 2012 after more than a decade without new drugs, and a third drug combination, naltrexone/bupropion, is undertaking a premarketing trial to assure cardiovascular safety. There is even a new formulation available for the old compound, phentermine, which was released ...
... finally released on the market in 2012 after more than a decade without new drugs, and a third drug combination, naltrexone/bupropion, is undertaking a premarketing trial to assure cardiovascular safety. There is even a new formulation available for the old compound, phentermine, which was released ...
0316065.01 - Society of Nuclear Medicine
... Method for Radiopharmaceuticals CMS is struggling to determine payment for one new radiopharmaceutical drug. We acknowledge that payment for radiopharmaceuticals presents unique challenges since they have all the features of drugs, plus additional clinical and technological attributes which can make ...
... Method for Radiopharmaceuticals CMS is struggling to determine payment for one new radiopharmaceutical drug. We acknowledge that payment for radiopharmaceuticals presents unique challenges since they have all the features of drugs, plus additional clinical and technological attributes which can make ...